Palacios, S., Colli, E., & Regidor, P. (2020). Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime. BMC Womens Health.
Chicago ZitierstilPalacios, Santiago, Enrico Colli, und Pedro-Antonio Regidor. "Efficacy and Cardiovascular Safety of the New Estrogen-free Contraceptive Pill Containing 4 mg Drospirenone Alone in a 24/4 Regime." BMC Womens Health 2020.
MLA ZitierstilPalacios, Santiago, Enrico Colli, und Pedro-Antonio Regidor. "Efficacy and Cardiovascular Safety of the New Estrogen-free Contraceptive Pill Containing 4 mg Drospirenone Alone in a 24/4 Regime." BMC Womens Health 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.